Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting

Company plans to showcase new volumetric MERFISH datasets in mouse brain and human neurodegenerative brain tissue, generated on the existing MERSCOPE Ultra™ Platform WALTHAM, Mass. -- Vizgen, Inc., a leader in spatial multiomics and developer of the MERSCOPE Ultra™ Platform, today announced it will debut a 3D Volumetric Tissue Mapping dataset in neurodegenerative brain tissue [...]

Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution

StrataMap Spatial gives researchers access to spatial biology at true single cell resolution for discovery without boundaries Whole-transcriptome profiling across a large tissue capture area can generate 2x more unique genes per sample than probe-based technologies SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth [...]

MilliporeSigma Appoints New Heads of Discovery Solutions and Strategy & BD

MilliporeSigma appoints Clara Sattler de Sousa e Brito and Robert Machinek to strengthen leadership team. Clara Sattler de Sousa e Brito appointed Head of Discovery Solutions, bringing extensive international leadership experience across healthcare, medtech and the chemical industry Robert Machinek appointed Head of Strategy & Business Development, bringing deep expertise in life science strategy, M&A [...]

Standard BioTools and Treeline Biosciences Announce Merger Agreement

Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates Company to be led by Treeline CEO and co-founder Josh Bilenker, MD, and experienced team of proven drug developers Treeline’s pipeline includes three Phase 1 programs with multiple anticipated clinical data readouts beginning in 2027 Well capitalized with over $900 million in cash expected [...]

Biolin Scientific elevates the Sigma force tensiometer line with a new product family

Biolin Scientific is proud to introduce the new Sigma family of force tensiometers, product line, designed to meet a broader range of surface and interfacial tension measurement needs. Built for both routine quality control and advanced research, the new Sigma family gives researchers and quality control professionals greater flexibility, performance, and confidence in their measurements. “Sigma has [...]

Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI

BILLERICA, Mass. - Bruker Corporation announced the commissioning of a novel BioSpec™ 18 Tesla preclinical MRI, the world’s highest-field horizontal-bore MRI system, at the Champalimaud Foundation in Lisbon, Portugal. The BioSpec 18T system provides increased spatial resolution and sensitivity, enabling advanced magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) methods for cancer and [...]

Biolin Scientific elevates the Sigma force tensiometer line with a new product family

Biolin Scientific is proud to introduce the new Sigma family of force tensiometers, product line, designed to meet a broader range of surface and interfacial tension measurement needs. Built for both routine quality control and advanced research, the new Sigma family gives researchers and quality control professionals greater flexibility, performance, and confidence in their measurements. “Sigma [...]

QLIMS Expands Across the Gulf and Jordan Genomics Market Through Strategic Partnership with Legion BioSolutions

Melbourne, Australia – Legion BioSolutions Limited and OnQ Software Pty Ltd are pleased to announce that they have signed a dealer agreement appointing Legion BioSolutions as the regional partner for QLIMS, OnQ Software’s flagship laboratory information management system, across the genomics sector in the United Arab Emirates, Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, and Jordan. Under [...]

SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center

SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK -- SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two [...]

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

WASHINGTON, D.C. - At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics. During the ASM 2026 meeting, Bruker showcases the expanded clinical capabilities of [...]

Access IBO on Knowledge Center